Technical Analysis for CABA - Cabaletta Bio, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 3.71 | 4.51% | 0.16 |
CABA closed up 4.51 percent on Friday, November 1, 2024, on 1.25 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 7
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | 4.51% | |
| Wide Bands | Range Expansion | 4.51% | |
| Lower Bollinger Band Touch | Weakness | 4.51% | |
| Oversold Stochastic | Weakness | 4.51% | |
| 20 DMA Resistance | Bearish | -2.11% | |
| New 52 Week Closing Low | Bearish | -2.11% | |
| 180 Bearish Setup | Bearish Swing Setup | -2.11% | |
| Reversal New Lows Setup | Bearish Swing Setup | -2.11% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 23 hours ago |
| Up 5% | about 23 hours ago |
| Up 3% | about 23 hours ago |
| Up 2% | about 23 hours ago |
| Down 1% | about 23 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Immunology Autoimmune Disease Antibodies Autoimmunity T Cell Sjögren Syndrome
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Immunology Autoimmune Disease Antibodies Autoimmunity T Cell Sjögren Syndrome
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 26.35 |
| 52 Week Low | 3.4713 |
| Average Volume | 884,234 |
| 200-Day Moving Average | 11.44 |
| 50-Day Moving Average | 4.48 |
| 20-Day Moving Average | 4.18 |
| 10-Day Moving Average | 4.00 |
| Average True Range | 0.37 |
| RSI (14) | 40.48 |
| ADX | 12.13 |
| +DI | 16.70 |
| -DI | 27.15 |
| Chandelier Exit (Long, 3 ATRs) | 3.85 |
| Chandelier Exit (Short, 3 ATRs) | 4.59 |
| Upper Bollinger Bands | 4.88 |
| Lower Bollinger Band | 3.48 |
| Percent B (%b) | 0.16 |
| BandWidth | 33.48 |
| MACD Line | -0.20 |
| MACD Signal Line | -0.15 |
| MACD Histogram | -0.0534 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.18 | ||||
| Resistance 3 (R3) | 4.15 | 3.98 | 4.10 | ||
| Resistance 2 (R2) | 3.98 | 3.86 | 3.99 | 4.07 | |
| Resistance 1 (R1) | 3.84 | 3.79 | 3.91 | 3.87 | 4.05 |
| Pivot Point | 3.67 | 3.67 | 3.70 | 3.68 | 3.67 |
| Support 1 (S1) | 3.53 | 3.55 | 3.60 | 3.56 | 3.37 |
| Support 2 (S2) | 3.36 | 3.48 | 3.37 | 3.35 | |
| Support 3 (S3) | 3.22 | 3.36 | 3.32 | ||
| Support 4 (S4) | 3.25 |
